Intracranial Emergencies and Intracranial Emergency Drugs

Core Concepts

The Monroe–Kellie doctrine: why pressure matters

The skull cannot expand. Its contents — brain tissue, blood, and CSF — normally occupy a fixed volume at a low pressure. When one compartment grows (edema, a hematoma, a tumor), the others must shrink to compensate. Once compensatory capacity is exhausted, intracranial pressure rises steeply, cerebral perfusion falls, and brain tissue can shift across anatomical boundaries — herniation — crushing vital brainstem structures. Early signs of rising ICP include headache, vomiting, decreasing level of consciousness, and pupil changes; the classic Cushing's triad of rising blood pressure, slowing heart rate, and irregular respirations is a late, ominous finding. Every intracranial emergency drug either stops the process adding volume (seizures, inflammation, clot) or removes volume (water, blood).

Status epilepticus: stopping the seizure storm

Status epilepticus is a seizure lasting longer than the defined emergency threshold or repeated seizures without recovery of consciousness in between. Untreated, it can become refractory — unresponsive to usual doses. First-line drugs are benzodiazepines (e.g., diazepam, lorazepam, midazolam), which enhance GABA-mediated inhibition in the brain and rapidly dampen seizure activity. They are short-acting, so a longer-acting antiseizure drug is typically given next to prevent recurrence — options include phenytoin/fosphenytoin, valproate, levetiracetam, or phenobarbital, chosen per protocol and the person's history. Refractory status epilepticus may require continuous infusion of anesthetic agents (e.g., propofol, midazolam, or barbiturates) with EEG monitoring — care that belongs in an intensive care setting. Nursing priorities include airway and respiratory depression monitoring (benzodiazepines and barbiturates suppress breathing), seizure precautions, IV access, and serial neurological assessment. All doses and sequences follow the current status-epilepticus protocol and prescriber orders.

Elevated ICP: osmotic and adjunctive therapy

Osmotic agents such as mannitol (and hypertonic saline) create an osmotic gradient that draws water out of the brain across the blood–brain barrier, temporarily reducing brain volume and ICP. Mannitol is an osmotic diuretic, so it also promotes fluid loss, and repeated dosing can disturb electrolytes (notably sodium and potassium) — the nurse monitors intake/output, electrolytes, and renal function. Corticosteroids (e.g., dexamethasone) are used specifically for vasogenic edema — the fluid leaking from abnormal vessels around brain tumors — because they reduce that vascular leakage; they are not first-line for the cytotoxic edema of stroke or trauma. Adjunctive measures are largely non-drug: head-of-bed elevation, avoiding hypoxia and hyperthermia, and careful fluid management. Verify agent, dose, and monitoring parameters against the institutional ICP protocol and prescriber orders.

Acute stroke: reperfusion and its limits

Ischemic stroke occurs when a clot blocks a cerebral artery. Thrombolytic therapy (e.g., alteplase, a tissue plasminogen activator) dissolves the clot and restores blood flow, but only within a strict time window from symptom onset and only after hemorrhage has been excluded by imaging. The benefit is dramatic; the risk is bleeding — most dangerously intracranial hemorrhage. Nursing priorities include documenting exact symptom-onset time, rapid administration per protocol, frequent neurological checks, blood pressure management, and watching for bleeding (new headache, vomiting, declining consciousness, oozing at puncture sites). Hemorrhagic stroke is the opposite problem: bleeding into the brain. Treatment focuses on controlling blood pressure and, if the person takes an anticoagulant, rapidly reversing it. Thrombolytics are absolutely contraindicated in hemorrhagic stroke — a classic exam trap. Selection and timing of any stroke therapy follow current guidelines, the stroke team's orders, and the institutional protocol.

The nurse's role across all three emergencies

The nurse is the constant presence: establishing baseline neurological status, documenting time of onset, protecting the airway, monitoring respirations, watching for adverse drug effects, and communicating changes immediately. Person-first language matters here too — these emergencies happen to a person with a family at the bedside. Scope of practice varies by jurisdiction and institution (for example, who may administer a benzodiazepine by a given route or titrate a continuous infusion), so the nurse practices within their license and facility policy, always verifying orders against the current formulary and references.

Common Confusions